Fetal heart rate and cardiotocographic abnormalities with varying dose misoprostol vaginal inserts

Objective: Characterize the incidence and timing of fetal heart rate (FHR) and cardiotocographic abnormalities (CTG) associated with the misoprostol vaginal insert (MVI) during labor induction. Methods: This secondary analysis of data from the MVI Trial, a multi-site, double-masked, randomized trial...

Full description

Saved in:
Bibliographic Details
Published in:The journal of maternal-fetal & neonatal medicine 2013-01, Vol.26 (2), p.127-131
Main Authors: Stephenson, Megan L., Powers, Barbara L., Wing, Deborah A.
Format: Article
Language:English
Subjects:
Administration, Intravaginal
Adult
Cardiotocography
Cesarean
Female
fetal intolerance
Heart Rate, Fetal - drug effects
Humans
labor induction
Labor, Induced - methods
Labor, Induced - statistics & numerical data
Misoprostol - administration & dosage
non-reassuring
Oxytocics - administration & dosage
Pregnancy
Pregnancy Outcome
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: Characterize the incidence and timing of fetal heart rate (FHR) and cardiotocographic abnormalities (CTG) associated with the misoprostol vaginal insert (MVI) during labor induction. Methods: This secondary analysis of data from the MVI Trial, a multi-site, double-masked, randomized trial of 374 women assigned to MVI 100, 150 or 200 mcg requiring cervical ripening before labor induction evaluated the incidence and clinical outcomes associated with FHR and CTG abnormalities diagnosed using 1997 NICHD definitions. Results: MVI 200 was associated with an increased rate of tachysystole versus MVI 100 (p < 0.001, RR 2.11, 95% CI 1.39, 3.22) but not MVI 150 (p = 0.29, RR 1.31, 95% CI 0.82, 2.11). Tachysystole occurred with the drug in situ in 17 (14.4%) and 50 (38.2%) of MVI 100 and 200 subjects, respectively (p < 0.001). Category II or III FHR patterns after tachysystole occurred in 9 (7.6%) and 26 (19.8%) women in MVI 100 and 200 groups, (p = 0.006). Abnormal FHR patterns were the indication for cesarean in 18 (13.7%) MVI 200 women versus 11 (9.3%) MVI 100 women (p = 0.33). Neonatal outcomes were similar between groups. Conclusions: While FHR and CTG abnormalities were encountered frequently during all inductions, few were clinically significant.
ISSN:1476-7058
1476-4954
DOI:10.3109/14767058.2012.703715